Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 493

1.

Progressive visual disturbance and enlarging prolactinoma caused by melanoma metastasis: A case report and literature review.

Yang C, Liu L, Lan X, Zhang S, Li X, Zhang B.

Medicine (Baltimore). 2017 Apr;96(14):e6483. doi: 10.1097/MD.0000000000006483. Review.

2.

Function and Clinical Implications of Long Non-Coding RNAs in Melanoma.

Richtig G, Ehall B, Richtig E, Aigelsreiter A, Gutschner T, Pichler M.

Int J Mol Sci. 2017 Mar 28;18(4). pii: E715. doi: 10.3390/ijms18040715. Review.

3.

Chemosaturation With Percutaneous Hepatic Perfusion in Unresectable Hepatic Metastases.

Glazer ES, Zager JS.

Cancer Control. 2017 Jan;24(1):96-101. Review.

4.

Neoplastic Meningitis Due to Lung, Breast, and Melanoma Metastases.

Le Rhun E, Taillibert S, Chamberlain MC.

Cancer Control. 2017 Jan;24(1):22-32. Review.

5.

Primary cerebral malignant melanoma: A case report with literature review.

Tang K, Kong X, Mao G, Qiu M, Zhu H, Zhou L, Nie Q, Xu Y, Du S.

Medicine (Baltimore). 2017 Jan;96(4):e5805. doi: 10.1097/MD.0000000000005805. Review.

6.

Diagnostic Clue of Meningeal Melanocytoma: Case Report and Review of Literature.

Lee JK, Rho YJ, Jeong DM, Rhim SC, Kim SJ.

Yonsei Med J. 2017 Mar;58(2):467-470. doi: 10.3349/ymj.2017.58.2.467. Review.

7.

The Multiple Roles of Exosomes in Metastasis.

Weidle UH, Birzele F, Kollmorgen G, Rüger R.

Cancer Genomics Proteomics. 2017 Jan 2;14(1):1-15. Review.

8.

Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis).

Jager MJ, Magner JA, Ksander BR, Dubovy SR.

Trans Am Ophthalmol Soc. 2016 Aug;114:T5. Review.

9.

Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses.

Komohara Y, Ohnishi K, Takeya M.

Cancer Sci. 2017 Mar;108(3):290-295. doi: 10.1111/cas.13137. Epub 2017 Mar 7. Review.

10.

The Pathophysiological Impact of HLA Class Ia and HLA-G Expression and Regulatory T Cells in Malignant Melanoma: A Review.

Johansen LL, Lock-Andersen J, Hviid TV.

J Immunol Res. 2016;2016:6829283. doi: 10.1155/2016/6829283. Epub 2016 Nov 23. Review.

11.

In the Wnt-er of life: Wnt signalling in melanoma and ageing.

Kaur A, Webster MR, Weeraratna AT.

Br J Cancer. 2016 Nov 22;115(11):1273-1279. doi: 10.1038/bjc.2016.332. Epub 2016 Oct 20. Review.

12.

Metastatic malignant melanoma of the urinary bladder: A case report and review of the literature.

Topal CS, Kır G, Daş T, Sarbay B, Tosun Mİ.

Indian J Pathol Microbiol. 2016 Oct-Dec;59(4):532-534. doi: 10.4103/0377-4929.191820. Review.

13.

Update on Ophthalmic Oncology 2014: Retinoblastoma and Uveal Melanoma.

Francis JH, Levin AM, Abramson DH.

Asia Pac J Ophthalmol (Phila). 2016 Sep-Oct;5(5):368-82. doi: 10.1097/APO.0000000000000213. Review.

14.

Melanoma Brain Metastasis: Mechanisms, Models, and Medicine.

Kircher DA, Silvis MR, Cho JH, Holmen SL.

Int J Mol Sci. 2016 Sep 2;17(9). pii: E1468. doi: 10.3390/ijms17091468. Review.

15.

Primary cerebral malignant melanoma in insular region with extracranial metastasis: case report and review literature.

Troya-Castilla M, Rocha-Romero S, Chocrón-González Y, Márquez-Rivas FJ.

World J Surg Oncol. 2016 Sep 1;14(1):235. doi: 10.1186/s12957-016-0965-7. Review.

16.

Metastatic disease from uveal melanoma: treatment options and future prospects.

Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD.

Br J Ophthalmol. 2017 Jan;101(1):38-44. doi: 10.1136/bjophthalmol-2016-309034. Epub 2016 Aug 29. Review.

17.

Proton therapy for the management of uveal melanoma and other ocular tumors.

Mishra KK, Daftari IK.

Chin Clin Oncol. 2016 Aug;5(4):50. doi: 10.21037/cco.2016.07.06. Review.

18.

Early analysis of surrogate endpoints for metastatic melanoma in immune checkpoint inhibitor trials.

Petrelli F, Coinu A, Cabiddu M, Borgonovo K, Ghilardi M, Lonati V, Barni S.

Medicine (Baltimore). 2016 Jun;95(26):e3997. doi: 10.1097/MD.0000000000003997. Review.

19.

Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.

Stei MM, Loeffler KU, Holz FG, Herwig MC.

Biomed Res Int. 2016;2016:4521807. doi: 10.1155/2016/4521807. Epub 2016 Jun 6. Review.

20.

Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.

Rajkumar S, Watson IR.

Br J Cancer. 2016 Jul 12;115(2):145-55. doi: 10.1038/bjc.2016.195. Epub 2016 Jun 23. Review.

Supplemental Content

Loading ...
Support Center